Stock Report

All about this stock under one free report Last Updated: 15-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Global Cord Blood - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$1.13

up-down-arrow $0.05 (4.63%)

As on 12-Jul-2023 09:30EDT

Market cap

info icon

$400 Mln

Revenue (TTM)

info icon

$1,225 Mln

P/E Ratio

info icon

5.1

P/B Ratio

info icon

0.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 0.00 -5.70 2.63 6.08 8.60
EBIT -- -- -24.66 4.63 12.31
Net Profit 4.06 -26.64 -15.07 11.32 21.02
EPS -95.35 -96.43 -27.52 4.55 8.92
Book Value -- -- 11.25 13.02 12.95
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-22Mar-21
EBIT-Margin info 47.2441.9636.9148.9746.99
Net Margin info --27.4138.59----
Return on equity info 12.0110.9016.8410.8212.30
Return on Capital info 12.0010.57--10.8212.29
Return on Assets info 6.555.738.466.106.72
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
--
10.82
12.29
12.89
8.92
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

16.84

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
16.84
10.82
12.30
12.90
8.92
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

8.46

--

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
8.46
6.10
6.72
6.84
4.70
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

36.91

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
36.91
48.97
46.99
45.77
35.71
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

38.59

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
38.59
40.30
43.83
38.54
29.50
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

2.63

--

Year on year growth in net sales

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
2.63
0.07
-0.05
0.24
0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-24.66

--

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
-24.66
11.75
-2.53
58.64
16.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-15.07

--

Year on year growth in profit after tax

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
-15.07
-1.41
7.97
61.69
22.79
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-27.52

--

Year on year growth in earnings per share

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
-27.52
-0.02
0.08
0.64
0.22
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-99.22

--

Year on year growth in book value per share

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
-99.22
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
--
0.00
0.00
0.00
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
--
0.00
0.00
0.00
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

10.73

--

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
10.73
10.73
10.05
9.93
8.64
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

10.66

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
10.66
10.66
9.98
9.85
8.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-327.54

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
-327.54
-15.79
-4.07
-11.35
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

2.08

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
2.08
12.97
11.24
8.53
10.92
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.22

--

Sales / Average Total Assets

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
0.22
0.15
0.15
0.18
0.16
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
--
42.83
36.94
31.69
41.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
--
89.80
89.82
68.92
54.32
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
--
17.74
30.08
51.72
44.12
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Global Cord Blood - ADR
--
114.89
96.69
48.89
51.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...